Prevalence and thrombotic risk of SGLT-2 inhibitor-associated erythrocytosis: a retrospective cohort study.
Lee JY, Lee JH, Jung EJ, Park W, Seo J, Kang M, Jung EH, Kim SA, Suh KJ, Kim JW, Kim SH, Lee JO, Kim JW, Kim YJ, Lee KW, Kim JH, Bang SM.
Lee JY, et al. Among authors: lee jo, lee jh.
Cardiovasc Diabetol. 2025 Jul 10;24(1):276. doi: 10.1186/s12933-025-02805-6.
Cardiovasc Diabetol. 2025.
PMID: 40640769